• iCAD (Nashua, New Hampshire) reported publication of peer-reviewed data on its SecondLook Computer-Aided Detection (CAD) technology in the February issue of the American Journal of Roentgenology. The article, titled "Detection of Breast Cancer with Full-Field Digital Mammography and Computer-Aided Detection," found the following: CAD with FFDM showed a high sensitivity in identifying cancers; The SecondLook CAD correctly marked 94% of biopsy-proven cancers; The sensitivity of iCAD's SecondLook CAD was not dependent on the size of the tumor; it was equally accurate with small and large lesions. iCAD says that the SecondLook Digital provides the most effective CAD technology that is designed to assist the radiologist in distinguishing cancers from other anomalies in the breast. SecondLook Digital is proficient at detecting subtle cancers, or those that are most likely to be missed. The company says SecondLook also provides workflow efficiencies that can improve the flow of patients within a mammography center.

• Lucid (Rochester, New York) said it has connected the first users to its VivaNet system, a telemedicine network designed to allow dermatologists and pathologists to share high-resolution images of suspicious skin lesions taken with the company's VivaScope confocal imagers. VivaNet is an Internet-based medical information system that facilitates secure, HIPAA-compliant, collaboration between dermatologists and pathologists in near real-time, providing images that these physicians can interpret for detection of skin cancers at the earliest, most curable stages. The VivaNet system transfers VivaScope images from dermatologists to pathologists so that together they can form more accurate clinical judgments regarding potential skin cancers. VivaNet also facilitates rapid second opinions, as necessary.

• Neuisys Imaging System Solutions (Greensboro, North Carolina) received FDA clearance of the NeuViz 16 Multi-Slice Computed Tomography (CT) system. "The NeuViz 16 is a state-of-the-art CT system that provides superior performance for the price and provides the clinical benefits of routine, sub-millimeter resolution, volume imaging and low-dose protocols," said Kim Russell, Neuisys president/CEO. "The NeuViz 16 packs a tremendous amount of technology into a very economical footprint and is the perfect solution for diagnostic imaging centers and community hospitals that plan to upgrade from older single or multi-slice CT systems to 16-slice CT as well as a wide array of specialist physician groups considering in-office CT including urologists, gastroenterologists, pulmonologists, surgeons, and oncologists."